Table 1A.
Clinical characteristics of the patients at pretreatment.
| Patient number | Age (yr) | Sex | Height (cm) | Weight (kg) | BMI (kg/m2) | Serum 25OHD (ng/ml) | Past fracture site | Years since the onset of AN | Past use of Bisphosphonate | Resumption of menstruation |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 41 | F | 150.2 | 22.8 | 10.1 | 8.4 | Vertebral body (L5) | 10 | 8 months | – |
| 2 | 31 | F | 148.4 | 27.8 | 12.6 | 23.0 | Vertebral body (T3, 5, 7, 8, 11, L4) | 16 | None | – |
| 3 | 41 | F | 160.0 | 32.0 | 12.5 | 28.2 | Pubis and sacrum | 21 | None | – |
| 4 | 36 | F | 156.0 | 41.0 | 16.8 | 30.4 | Femoral greater trochanter | 7 | 7 years | + |
| 5 | 40 | F | 163.0 | 47.0 | 17.7 | 8.5 | Femoral neck | 21 | None | + |
| Mean | 37.8 | 155.2 | 34.1 | 14.0 | 19.7 | 15.0 | ||||
| SD | 4.3 | 6.2 | 9.8 | 3.2 | 10.6 | 6.4 |
SD, standard deviation; BMI, body mass index, 25OHD, 25 hydroxyvitamin D, AN, anorexia nervosa.